Analyst Price Targets — BWAY
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 26, 2026 11:07 am | — | H.C. Wainwright | $15.00 | $11.52 | TheFly | Brainsway price target raised to $30 from $24 at H.C. Wainwright |
| January 22, 2026 2:01 pm | — | Northland Securities | $15.00 | $12.30 | TheFly | Brainsway price target raised to $30 from $23 at Northland |
| December 8, 2025 11:15 am | Raghuram Selvaraju | H.C. Wainwright | $12.00 | $8.64 | TheFly | Brainsway price target raised to $24 from $18 at H.C. Wainwright |
| August 7, 2024 6:14 am | Raghuram Selvaraju | H.C. Wainwright | $8.00 | $3.45 | TheFly | Brainsway price target raised to $16 from $15 at H.C. Wainwright |
| May 9, 2024 7:36 am | Steven Lichtman | Oppenheimer | $5.50 | $2.85 | StreetInsider | Brainsway (BWAY) PT Raised to $11 at Oppenheimer |
| May 9, 2024 6:42 am | Raghuram Selvaraju | H.C. Wainwright | $7.50 | $2.85 | StreetInsider | Brainsway (BWAY) PT Raised to $15 at H.C. Wainwright |
| November 17, 2022 9:50 am | — | Northland Securities | $2.50 | $0.99 | Benzinga | Northland Capital Markets Maintains Outperform on BrainsWay, Lowers Price Target to $5 |
| August 22, 2022 6:21 am | — | H.C. Wainwright | $8.00 | $2.46 | Benzinga | HC Wainwright & Co. Maintains Buy on BrainsWay, Raises Price Target to $16 |
| August 11, 2022 7:35 am | — | Raymond James | $4.00 | $2.84 | Benzinga | Raymond James Maintains Outperform on BrainsWay, Lowers Price Target to $8 |
Latest News for BWAY
On April 16, 2026, BrainsWay Ltd (BWAY) shares fell 3.0% today to a current price of $15.33. Over the past year, the stock has seen a remarkable increase of 267
Growing payer acceptance of nurse practitioner administration of Deep TMS is expected to expand access to non‑drug mental health treatments Growing payer acceptance of nurse practitioner administration of Deep TMS is expected to expand access to non‑drug mental health treatments
Brainsway (BWAY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Brainsway (BWAY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
BURLINGTON, Mass. and JERUSALEM, April 13, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that management will present at the 25th Annual Needham Virtual Healthcare Conference at 8:45 AM ET on Wednesday, April 15, 2026.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for BWAY.
U.S. House Trading
No House trades found for BWAY.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.